<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03495986</url>
  </required_header>
  <id_info>
    <org_study_id>20190659</org_study_id>
    <secondary_id>R01HD091278-01</secondary_id>
    <secondary_id>6996</secondary_id>
    <nct_id>NCT03495986</nct_id>
  </id_info>
  <brief_title>Spinal Cord Injury Exercise and Nutrition Conceptual Engagement</brief_title>
  <acronym>SCIENCE</acronym>
  <official_title>Spinal Cord Injury Exercise and Nutrition Conceptual Engagement (SCIENCE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate and compare the health benefits of an at home exercise program using functional&#xD;
      electrical stimulation (FES) for lower extremity exercise with diet versus a diet alone group&#xD;
      in adults with spinal cord injury.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this proposal is to evaluate and compare the health benefits of home-based&#xD;
      functional electrical stimulation leg cycle ergometry plus diet (HBFESLCE + Diet) to&#xD;
      home-based (HB) Diet alone. This is a randomized, baseline-controlled, prospective,&#xD;
      interventional trial to assess the impact of a 16-week exercise and/or diet intervention on&#xD;
      selected fitness parameters in adults with high SCI. Primary outcome measures will include&#xD;
      body composition by iDXA, insulin sensitivity, glucose effectiveness and BMR, while secondary&#xD;
      outcomes will include lower extremity BMC and density, lipid profiles, and hsCRP determined&#xD;
      before and after the 16-week interventions. Subjects will be randomly assigned to either&#xD;
      HBFES LCE + Diet on an RT300 ergometer or Home-based (HB) Diet Alone intervention. Both&#xD;
      groups will be routinely monitored via telemedicine while at home.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in percent Body fat</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>Percent body fat will be assessed in percentage using Dual Energy x-ray absorbency (DXA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Fat Mass</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>Absolute Fat mass (FM) and Absolute Fat free mass (FFM) will be assessed in kilograms using DXA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Insulin Sensitivity (Si)</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>Insulin Sensitivity will be measured using intravenous glucose tolerance test (IVGTT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Glucose effectiveness (Sg)</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>Glucose Effectiveness will be measured using IVGTT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Basal Metabolic Rate (BMR)</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>BMR will be measured by indirect calorimetry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in High Density Lipoprotein cholesterol (HDL-C) level</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>HDL-C will be measured from blood serum samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total cholesterol : HDL-C ratio</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>Total Cholesterol HDL-C ratio will be measured from blood serum samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in High sensitivity C-Reactive Protein (hsCRP) level</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>hsCRP will be measured from blood serum samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lower Extremity Bone Mineral Density (BMD)</measure>
    <time_frame>Baseline, 21 weeks</time_frame>
    <description>BMD will be measured using DXA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Dietary Modification</condition>
  <condition>Paraplegia</condition>
  <condition>Tetraplegia</condition>
  <arm_group>
    <arm_group_label>Home-Based Exercise &amp; Diet Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16-week home based functional electrical stimulation leg cycle ergometry exercise program and diet intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Home-Based Diet Alone Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Diet intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Functional Electrical Stimulation Leg Cycle Ergometry</intervention_name>
    <description>Exercise training will consist of three to five, 40-67 minute sessions (200 minutes at target intensity) each week for a total of 16 weeks at 70% maximal heart rate; 10-minute warm-up and cool-down sessions will accompany each exercise session.</description>
    <arm_group_label>Home-Based Exercise &amp; Diet Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>An individualized, detailed dietary plan consistent with My Healthy Plate Dietary Guidelines of America will be followed under supervision of Registered Dietitian with weekly telemedicine conferences and monitored dietary intake via MyFitnessPal.</description>
    <arm_group_label>Home-Based Diet Alone Group</arm_group_label>
    <arm_group_label>Home-Based Exercise &amp; Diet Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Adults 18-65 years of age (inclusive)&#xD;
&#xD;
          -  Sex: male or female&#xD;
&#xD;
          -  Women of child-bearing potential who agree to refrain from getting pregnant during the&#xD;
             trial&#xD;
&#xD;
          -  C4-T4 motor complete (AIS A&amp;B) spinal cord injury for duration greater than 12 months&#xD;
&#xD;
          -  &lt;5% change in body weight over the past 12 months&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  &lt;22% body fat&#xD;
&#xD;
          -  Unresponsive to neurostimulation&#xD;
&#xD;
          -  Those who have participated in an FES or ACE exercise program (&gt;60 minutes/week)&#xD;
             within the past 3 months&#xD;
&#xD;
          -  Known orthopaedic limitations&#xD;
&#xD;
          -  Coronary artery disease&#xD;
&#xD;
          -  Type 1 diabetes mellitus, insulin-requiring Type 2 or untreated diabetes mellitus&#xD;
             (fasting glucose&gt;126 or HgbA1c&gt;7.0)&#xD;
&#xD;
          -  Uncompensated Hypothyroidism (Stable on medication &gt;1 year or not on medication)&#xD;
&#xD;
          -  Renal disease&#xD;
&#xD;
          -  Uncontrolled autonomic dysreflexia, recent (within 3 months)&#xD;
&#xD;
          -  Deep vein thrombosis&#xD;
&#xD;
          -  Pressure ulcers &gt; Grade II&#xD;
&#xD;
          -  Decisional impairment&#xD;
&#xD;
          -  Any potential causes of autonomic dysreflexia at the discretion of the PI&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Pregnant or nursing women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Gater, MD, PhD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Gater, D, PhD, MS</last_name>
    <phone>305-243-9516</phone>
    <email>dgater@miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinorah Rodriguez, RN, BSN</last_name>
      <phone>305-243-2797</phone>
      <email>dinorah@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>David Gater, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 2, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>David Gater</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Functional Electrical Stimulation</keyword>
  <keyword>Exercise</keyword>
  <keyword>Body Composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
    <mesh_term>Quadriplegia</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

